Modified Rodnan Skin Score in Scleroderma Using 17 Sites

Purpose: To evaluate skin involvement in a patient with scleroderma using the 17 site modification of the Rodnan skin score.

Info MyLikes MyPaths

Evaluation

Are you evaluating skin involvement in a patient with scleroderma?

Yes

Select an appropriate answer for the extent of skin thickening seen in each area

Face

Anterior chest

Abdomen

Left fingers

Dorsum left hand

Left forearm

Left upper arm

Right fingers

Dorsum right hand

Right forearm

Right upper arm

Left thigh

Left lower leg

Dorsum left foot

Right thigh

Right lower leg

Dorsum right foot

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Modified Rodnan skin score

Which is

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Scleroderma Risk Model for 5 Year Survival
Clinical Diagnosis, Including Family History For Genetics
- ARA Scleroderma Criteria Cooperative Study Preliminary Clinical Criteria for Systemic Sclerosis
Imaging Studies
Laboratory Tests
Other Testing
Criteria For Diagnosis
Severity, Prognosis, Stage
Differential Diagnosis And Mimics, Red Flags

Therapy

Physical And Lifestyle
- Drug Induced Scleroderma

Monitoring

Response To Therapy
Disease Progression
Comorbid Conditions
- Prognostic Factors for Patient with Juvenile Systemic Sclerosis
- Lung Severity Scale of Medsger for Patient with Systemic Sclerosis

Patient Concerns

End-of-life, Palliative Care
- Scleroderma Risk Model for 5 Year Survival

Specialty

Immunology/Rheumatology

Objective

severity
prognosis
stage

ICD-10

M34 - Systemic sclerosis

Info

Purpose: To evaluate skin involvement in a patient with scleroderma using the 17 site modification of the Rodnan skin score.

Specialty: Immunology/Rheumatology

Objective: severity, prognosis, stage

ICD-10: M34,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path